USA flag logo/image

An Official Website of the United States Government

SBIR Phase I: Cost-Effective Anastomotic System Featuring Compliant Anastomoses

Award Information

Agency:
National Science Foundation
Branch:
N/A
Award ID:
Program Year/Program:
2011 / SBIR
Agency Tracking Number:
1046481
Solicitation Year:
2010
Solicitation Topic Code:
BC
Solicitation Number:
Small Business Information
Sterling biomedical
2 DURHAM DR Lynnfield, MA 01940-1238
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2011
Title: SBIR Phase I: Cost-Effective Anastomotic System Featuring Compliant Anastomoses
Agency: NSF
Contract: 1046481
Award Amount: $149,979.00
 

Abstract:

This Small Business Innovation Research (SBIR) Phase I project aims to develop a mechanical system for facilitating vascular anastomoses (end-to-side, end-to-end) technology that allows for the rapid and reproducible production of a non-penetrating, compliant vascular reconstruction. This one-shot technology represents a technical advance over the serial clip applier because the entire anastomotic circumference is formed simultaneously, thus facilitating the vascular reconstruction. Currently, there are no one-shot anastomotic systems on the market, thus the proposed technology would fill that much needed demand. This Phase I effort also will develop the manufacturing methods needed to produce these low-cost anastomotic devices that feature compliant polyurethane clips. Bench testing of the anastomoses will be conducted using well-established in vitro procedures. The broader impact/commercial potential of this project will be to reduce the time required to perform vascular anastomoses as well as vascular reconstruction in beating heart surgery. The $400 million surgical staples market urgently needs a new technology, as there is a significant unmet need to develop a novel, sutureless anastomotic device that applies 10 or 12 circumferential clips simultaneously. This should lead to rapid commercialization, especially since this advanced system will reduce surgical operating time.

Principal Investigator:

Michael Szycher
7819566969
Drszycher@aol.com

Business Contact:

Michael Szycher
PhD
7819566969
Drszycher@aol.com
Small Business Information at Submission:

STERLING BIOMEDICAL, LLC
2 DURHAM DR Lynnfield, MA 01940-1238

EIN/Tax ID: 262577114
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No